ETHYPHARM UK LIMITED
Get an alert when ETHYPHARM UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-08 (in 6mo)
Last made up 2025-10-25
Watchouts
None on the register
Cash
£222K
+192.1% vs 2023
Net assets
£13M
+2.6% vs 2023
Employees
89
+1.1% vs 2023
Profit before tax
£443K
-3.1% vs 2023
Name history
Renamed 2 times since incorporation
- ETHYPHARM UK LIMITED 2016-07-19 → present
- DB ASHBOURNE LIMITED 2014-01-17 → 2016-07-19
- DALLAS BURSTON PHARMA LIMITED 2013-06-11 → 2014-01-17
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £10,829,000 | £14,973,000 | |
| Operating profit | £457,000 | £443,000 | |
| Profit before tax | £457,000 | £443,000 | |
| Net profit | £457,000 | £324,000 | |
| Cash | £76,000 | £222,000 | |
| Total assets less current liabilities | £12,498,000 | £12,822,000 | |
| Net assets | £12,498,000 | £12,822,000 | |
| Equity | £12,498,000 | £12,822,000 | |
| Average employees | 88 | 89 | |
| Wages | £5,566,000 | £6,361,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 4.2% | 3.0% | |
| Net margin | 4.2% | 2.2% | |
| Return on capital employed | 3.7% | 3.5% | |
| Current ratio | 2.72x | 2.02x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors consider, after making appropriate enquiries, that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.”
Significant events
- “As part of a strategic realignment within the UK group aimed at consolidating product focus across entities, responsibility for the sale of the opioid addiction branded product portfolio was transferred from fellow group company, Macarthys Laboratories Limited, to the Company in September 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 13 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| RUYANT, Foucauld | Secretary | 2024-09-30 | — | — |
| DE ULTRA DE SOUSA BARCELOS, Bruno | Director | 2023-01-17 | Aug 1973 | Portuguese |
| LASSERRE, Xavier Pierre Christian | Director | 2023-06-26 | Apr 1972 | French |
| MEHRAI, Alexander | Director | 2025-01-31 | Jun 1975 | British |
| RUYANT, Foucauld | Director | 2024-09-30 | Oct 1975 | French |
Show 13 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BURSTON, Sallyann | Secretary | 2013-06-11 | 2015-09-30 |
| BOVOLENTA, Andrea | Director | 2024-03-01 | 2024-06-05 |
| BURSTON, Dallas John, Dr | Director | 2013-06-11 | 2015-09-30 |
| CONCANNON, Paul Joseph | Director | 2019-03-12 | 2025-01-31 |
| DELUARD, Bertrand | Director | 2019-07-21 | 2022-09-13 |
| FARRANT, Andrew David | Director | 2015-09-30 | 2018-02-28 |
| JOANNESSE, Roseline Georgette | Director | 2018-03-30 | 2019-03-12 |
| LECAT, Jean-Hugues Louis Marie | Director | 2015-09-30 | 2019-07-21 |
| LIEPMANN, Susanne | Director | 2015-09-30 | 2018-03-30 |
| MONIN, Jean Bernard Claude | Director | 2022-11-01 | 2023-06-26 |
| PARRY, Philip Edward | Director | 2019-03-12 | 2022-12-31 |
| SCHMIDT, Emmanuel | Director | 2019-03-12 | 2022-12-31 |
| TOMKINS, Lisa Elaine | Director | 2018-02-28 | 2019-01-18 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dallas Burston Ashbourne Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 78 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-10-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-22 | AA | accounts | Accounts with accounts type full | |
| 2025-01-31 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-31 | AP01 | officers | Appoint person director company with name date | |
| 2024-12-12 | AA | accounts | Accounts with accounts type full | |
| 2024-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-17 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-17 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-10-17 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-01 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-03 | AA | accounts | Accounts with accounts type full | |
| 2023-07-10 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-10 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-27 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-27 | AP01 | officers | Appoint person director company with name date | |
| 2023-01-27 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-07 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-23 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+38.3%
£10,829,000 £14,973,000
-
Cash
+192.1%
£76,000 £222,000
-
Net assets
+2.6%
£12,498,000 £12,822,000
-
Employees
+1.1%
88 89
-
Operating profit
-3.1%
£457,000 £443,000
-
Profit before tax
-3.1%
£457,000 £443,000
-
Wages
+14.3%
£5,566,000 £6,361,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers